Meeting
2017 Genitourinary Cancers Symposium
Next generation sequencing of non-muscle invasive bladder cancer to reveal potential biomarkers and rational therapeutic targets.
Authors
Eugene J. Pietzak III
Memorial Sloan Kettering Cancer Center, New York, NY
Eugene J. Pietzak III, Eugene K. Cha , Aditya Bagrodia , Esther N. Drill , Gopa Iyer , Sumit Isharwal , Qiang Li , Priscilla Baez , Michael F. Berger , Ahmet Zehir , Irina Ostrovnaya , Nikolaus Schultz , Dean F. Bajorin , Jonathan E. Rosenberg , Guido Dalbagni , Hikmat Al-Ahmadie , David B. Solit , Bernard H. Bochner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 302)
DOI
10.1200/JCO.2017.35.6_suppl.302
Abstract #
302
Poster Bd #
E15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2023 ASCO Genitourinary Cancers Symposium
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
First Author: Tanya Jindal
Poster
2024 ASCO Genitourinary Cancers Symposium
Performance of the OncoUrine test on predicting patients who can avoid Re-TURBT and prognosis: A prospective, multicenter clinical study.
First Author: Xiao Yang
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari